Yenal Dundar

Summary

Affiliation: University of Liverpool
Country: UK

Publications

  1. ncbi request reprint Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis
    Yenal Dundar
    The University of Liverpool, Faculty of Medicine, Liverpool Reviews and Implementation Group, The Sherrington Buildings, Ashton Street, Liverpool L69 3GE, UK
    Hum Psychopharmacol 19:305-22. 2004
  2. ncbi request reprint Angioplasty and stents in coronary artery disease: a systematic review and meta-analysis
    Yenal Dundar
    The University of Liverpool, Faculty of Medicine, Liverpool Reviews and Implementation Group, Liverpool, UK
    Scand Cardiovasc J 38:200-10. 2004
  3. ncbi request reprint Searching for and use of conference abstracts in health technology assessments: policy and practice
    Yenal Dundar
    Liverpool Reviews and Implementation Group, Faculty of Medicine, University of Liverpool, UK
    Int J Technol Assess Health Care 22:283-7. 2006
  4. ncbi request reprint Case study of the comparison of data from conference abstracts and full-text articles in health technology assessment of rapidly evolving technologies: does it make a difference?
    Yenal Dundar
    Liverpool Reviews and Implementation Group, Faculty of Medicine, University of Liverpool, UK
    Int J Technol Assess Health Care 22:288-94. 2006
  5. pmc Erlotinib and gefitinib for treating non-small cell lung cancer that has progressed following prior chemotherapy (review of NICE technology appraisals 162 and 175): a systematic review and economic evaluation
    Janette Greenhalgh
    Liverpool Reviews and Implementation Group, University of Liverpool, Liverpool, UK
    Health Technol Assess 19:1-134. 2015
  6. doi request reprint Dabrafenib for Treating Unresectable, Advanced or Metastatic BRAF V600 Mutation-Positive Melanoma: An Evidence Review Group Perspective
    Nigel Fleeman
    Liverpool Reviews and Implementation Group, University of Liverpool, Whelan Building, Liverpool, L69 3GB, UK
    Pharmacoeconomics 33:893-904. 2015
  7. doi request reprint Vemurafenib for the treatment of locally advanced or metastatic BRAF V600 mutation-positive malignant melanoma: a NICE single technology appraisal
    Sophie Beale
    Liverpool Reviews and Implementation Group, University of Liverpool, Whelan Building, Brownlow Hill, Liverpool, L69 3GB, UK
    Pharmacoeconomics 31:1121-9. 2013
  8. doi request reprint Eribulin for the treatment of advanced or metastatic breast cancer: a NICE single technology appraisal
    Janette Greenhalgh
    Liverpool Reviews and Implementation Group, University of Liverpool, Whelan Building, Liverpool, L69 3GB, UK
    Pharmacoeconomics 33:137-48. 2015
  9. pmc Rituximab for the first-line maintenance treatment of follicular non-Hodgkin's lymphoma : a NICE single technology appraisal
    Janette Greenhalgh
    Liverpool Reviews and Implementation Group, University of Liverpool, 2nd Floor, Whelan Building, The Quadrangle, Brownlow Hill, Liverpool, L69 3 GB, UK
    Pharmacoeconomics 31:403-13. 2013
  10. pmc Prasugrel (Efient®) with percutaneous coronary intervention for treating acute coronary syndromes (review of TA182): systematic review and economic analysis
    Janette Greenhalgh
    Liverpool Reviews and Implementation Group, University of Liverpool, Liverpool, UK
    Health Technol Assess 19:1-130. 2015

Collaborators

Detail Information

Publications19

  1. ncbi request reprint Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis
    Yenal Dundar
    The University of Liverpool, Faculty of Medicine, Liverpool Reviews and Implementation Group, The Sherrington Buildings, Ashton Street, Liverpool L69 3GE, UK
    Hum Psychopharmacol 19:305-22. 2004
    ....
  2. ncbi request reprint Angioplasty and stents in coronary artery disease: a systematic review and meta-analysis
    Yenal Dundar
    The University of Liverpool, Faculty of Medicine, Liverpool Reviews and Implementation Group, Liverpool, UK
    Scand Cardiovasc J 38:200-10. 2004
    ..To undertake a systematic review of the clinical effectiveness of routine percutaneous transluminal coronary angioplasty (PTCA) plus stenting vs PTCA alone...
  3. ncbi request reprint Searching for and use of conference abstracts in health technology assessments: policy and practice
    Yenal Dundar
    Liverpool Reviews and Implementation Group, Faculty of Medicine, University of Liverpool, UK
    Int J Technol Assess Health Care 22:283-7. 2006
    ..Current policy and practice regarding identification of and extent of use of data from conference abstracts in health technology assessment reviews (TARs) are examined...
  4. ncbi request reprint Case study of the comparison of data from conference abstracts and full-text articles in health technology assessment of rapidly evolving technologies: does it make a difference?
    Yenal Dundar
    Liverpool Reviews and Implementation Group, Faculty of Medicine, University of Liverpool, UK
    Int J Technol Assess Health Care 22:288-94. 2006
    ....
  5. pmc Erlotinib and gefitinib for treating non-small cell lung cancer that has progressed following prior chemotherapy (review of NICE technology appraisals 162 and 175): a systematic review and economic evaluation
    Janette Greenhalgh
    Liverpool Reviews and Implementation Group, University of Liverpool, Liverpool, UK
    Health Technol Assess 19:1-134. 2015
    ..One-third of these patients receive further treatment following disease progression; these treatments are the focus of this systematic review...
  6. doi request reprint Dabrafenib for Treating Unresectable, Advanced or Metastatic BRAF V600 Mutation-Positive Melanoma: An Evidence Review Group Perspective
    Nigel Fleeman
    Liverpool Reviews and Implementation Group, University of Liverpool, Whelan Building, Liverpool, L69 3GB, UK
    Pharmacoeconomics 33:893-904. 2015
    ..Since the overall costs of these two drugs were similar, the AC recommended the use of dabrafenib in patients with unresectable, advanced or metastatic BRAF V600 mutation-positive melanoma. ..
  7. doi request reprint Vemurafenib for the treatment of locally advanced or metastatic BRAF V600 mutation-positive malignant melanoma: a NICE single technology appraisal
    Sophie Beale
    Liverpool Reviews and Implementation Group, University of Liverpool, Whelan Building, Brownlow Hill, Liverpool, L69 3GB, UK
    Pharmacoeconomics 31:1121-9. 2013
    ....
  8. doi request reprint Eribulin for the treatment of advanced or metastatic breast cancer: a NICE single technology appraisal
    Janette Greenhalgh
    Liverpool Reviews and Implementation Group, University of Liverpool, Whelan Building, Liverpool, L69 3GB, UK
    Pharmacoeconomics 33:137-48. 2015
    ..The AC concluded that the evidence had not demonstrated sufficient benefit in OS, cost effectiveness or HRQoL and that eribulin was not recommended for use in this patient group...
  9. pmc Rituximab for the first-line maintenance treatment of follicular non-Hodgkin's lymphoma : a NICE single technology appraisal
    Janette Greenhalgh
    Liverpool Reviews and Implementation Group, University of Liverpool, 2nd Floor, Whelan Building, The Quadrangle, Brownlow Hill, Liverpool, L69 3 GB, UK
    Pharmacoeconomics 31:403-13. 2013
    ..At a third meeting, the AC concluded that RTX could be recommended as first-line maintenance treatment for patients with fNHL whose disease has responded to induction R-CTX...
  10. pmc Prasugrel (Efient®) with percutaneous coronary intervention for treating acute coronary syndromes (review of TA182): systematic review and economic analysis
    Janette Greenhalgh
    Liverpool Reviews and Implementation Group, University of Liverpool, Liverpool, UK
    Health Technol Assess 19:1-130. 2015
    ..Prasugrel is the focus of this review...
  11. doi request reprint Pertuzumab in combination with trastuzumab and docetaxel for the treatment of HER2-positive metastatic or locally recurrent unresectable breast cancer
    Nigel Fleeman
    Liverpool Reviews and Implementation Group, University of Liverpool, Whelan Building, Liverpool, L69 3GB, UK
    Pharmacoeconomics 33:13-23. 2015
    ..At the time of writing, NICE had not made a final decision regarding this technology but had instead referred the issue of the assessment of technologies that are not effective at a zero price to their Decision Support Unit for advice. ..
  12. pmc The clinical effectiveness and cost-effectiveness of the PROGENSA® prostate cancer antigen 3 assay and the Prostate Health Index in the diagnosis of prostate cancer: a systematic review and economic evaluation
    Amanda Nicholson
    Liverpool Reviews and Implementation Group, University of Liverpool, Liverpool, UK
    Health Technol Assess 19:i-xxxi, 1-191. 2015
    ..Brea, CA, USA) are two new tests (a urine test and a blood test, respectively) that are designed to be used to help clinicians decide whether or not to recommend a repeat biopsy...
  13. doi request reprint Erlotinib monotherapy for the maintenance treatment of non-small cell lung cancer after previous platinum-containing chemotherapy: a NICE single technology appraisal
    Rumona Dickson
    Liverpool Reviews and Implementation Group, University of Liverpool, Liverpool, UK
    Pharmacoeconomics 29:1051-62. 2011
    ..All values were above NICE's perceived willingness-to-pay threshold. After the second Appraisal Committee meeting, the Committee did not recommend the use of erlotinib in this patient population...
  14. ncbi request reprint Drug-eluting stents: an early systematic review to inform policy
    Ruaraidh A Hill
    Liverpool Reviews and Implementation Group, The Sherrington Buildings, Ashton Street, Liverpool L69 3GE, UK
    Eur Heart J 25:902-19. 2004
    ..To provide systematic assessment of the clinical effectiveness of drug-eluting stents (DES) versus non-DES to inform national guidance...
  15. doi request reprint Moderators of the effect of psychological interventions on depression and anxiety in cardiac surgery patients: A systematic review and meta-analysis
    Cleo Protogerou
    Institute of Psychology Health and Society, Department of Health Services Research, University of Liverpool, Room 1 88, Eleanor Rathbone Building, 74 Bedford Street South, Liverpool, L69 7ZQ, UK Department of Psychology, University of Cape Town, Rondebosch, 7701, South Africa Electronic address
    Behav Res Ther 73:151-64. 2015
    ..In addition to estimating efficacy, future work in this domain needs to take into account the moderating effects of intervention, sample, and study characteristics...
  16. pmc Allopurinol for the treatment of chronic kidney disease: a systematic review
    Nigel Fleeman
    Liverpool Reviews and Implementation Group, University of Liverpool, Liverpool, UK
    Health Technol Assess 18:1-77, v-vi. 2014
    ..People with CKD have an increased prevalence of cardiovascular disease (CVD). Evidence is emerging that allopurinol may have a role to play in slowing down the progression of CKD and reducing the risk of CVD...
  17. pmc A scoping study to explore the cost-effectiveness of next-generation sequencing compared with traditional genetic testing for the diagnosis of learning disabilities in children
    Sophie Beale
    Liverpool Reviews and Implementation Group LRiG, University of Liverpool, Liverpool, UK
    Health Technol Assess 19:1-90. 2015
    ..Some cases of LD with unidentified causes may be linked to genetic factors. Next-generation sequencing (NGS) techniques are new approaches to genetic testing that are expected to increase diagnostic yield...
  18. doi request reprint Cetuximab for recurrent and/or metastatic squamous cell carcinoma of the head and neck: a NICE single technology appraisal
    Adrian Bagust
    Liverpool Reviews and Implementation Group, University of Liverpool, Liverpool L69 3GB, UK
    Pharmacoeconomics 28:439-48. 2010
    ..This was the first appraisal to consider the end-of-life medicines criteria introduced by NICE in January 2009...
  19. doi request reprint Biofeedback for hypertension: a systematic review
    Janette Greenhalgh
    Liverpool Reviews and Implementation Group, University of Liverpool, Brownlow Hill, Liverpool, UK
    J Hypertens 28:644-52. 2010
    ..To assess the evidence for the long-term effectiveness of biofeedback for the treatment of essential hypertension in adults...